Interventions for Tuberculosis Control and Elimination 2002

341. Crowle AJ, Sbarbaro JA, Judson FN, May MH. The effect of ethambutol on
tubercle bacilli within cultured human macrophages.
132: 742-5.
Am Rev Respir Dis 1985;
342. Takayama K, Kilburn JO. Inhibition of synthesis of arabinogalactan by ethambutol
in Mycobacterium smegmatis.
1493-9.
Antimicrob Agents Chemother 1989; 33:
343. Deng L, Mikusová K, Robuck KG, Scherman M, Brennan PJ, McNeil MR.
Recognition of multiple effects of ethambutol on metabolism of mycobacterial
cell envelope. Antimicrob Agents Chemother 1995; 39: 694-701.
344. Mikusová K, Slayden RA, Besra GS, Brennan PJ. Biogenesis of the mycobacterial
cell wall and the site of action of ethambutol.
1995; 39: 2484-9.
Antimicrob Agents Chemother
345. David HL, Laszlo A, Rastogi N. Mode of action of antimycobacterial drugs.
Acta Leprologica 1989; 7 (Suppl 1): 189-94.
346. Kilburn JO, Greenberg J. Effect of ethambutol on the viable cell count in
Mycobacterium smegmatis. Antimicrob Agents Chemother 1977; 11: 534-40.
347. Hoffner SE, Svenson SB, Källenius G. Synergistic effects of antimycobacterial
drug combinations on Mycobacterium avium complex determined radiometrically
in liquid medium. Eur J Clin Microbiol 1987; 6: 530-5.
348. Rastogi N, David HL. Mode of action of antituberculous drugs and mechanisms
of drug resistance in Mycobacterium tuberculosis.
133-43.
Res Microbiol 1993; 144:
349. Place VA, Thomas JP.
Dis 1963; 87:901-4.
Clinical pharmacology of ethambutol. Am Rev Respir
350. Peets EA, Sweeney WM, Place VA, Buyske DA. The absorption, excretion, and
metabolic fate of ethambutol in man. Am Rev Respir Dis 1965; 91: 51-8.
351. Peloquin CA. Pharmacology of the antimycobacterial drugs. Med Clin N Amer
1993; 77: 1253-62.
352. Kelly RG, Kaleita E, Eisner HJ. Tissue distribution of ( 14C)Ethambutol in mice.
Am Rev Respir Dis 1981; 123: 689-90.
353. Liss RH, Letourneau J, Schepis JP. Distribution of ethambutol in primate tissues
and cells. Am Rev Respir Dis 1981; 123: 529-32.
354. Varughese A, Brater DC, Benet LZ, Lee CSC. Ethambutol kinetics in patients
with impaired renal function. Am Rev Respir Dis 1986; 134: 34-8.
355. Peloquin CA, Bulpitt AE, Jaresko GSJ, Jelliffe RW, Childs JM, Nix DE.
Pharmacokinetics of ethambutol under fasting conditions, with food, and with
antacids. Antimicrob Agents Chemother 1999; 43: 568-72.
356. American Thoracic Society, Centers for Disease Control, American Academy of
Pediatrics. Treatment of tuberculosis and tuberculosis infection in adults and
children. Am J Respir Crit Care Med 1994; 149: 1359-74.
192